China Grants Patent for Imugene's Oncolytic Virotherapy CF33 miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Imugene granted China patent for Oncolytic Virotherapy CF33 proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Guess which ASX 300 healthcare stock is storming higher on Chinese patent news fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.
Imugene Ltd (ASX:IMU, OTC:IUGNF) has cleared the cohort 3 intratumoral (IT) arm of the monotherapy dose escalation study in its Phase 1 metastatic advanced.
Imugene Ltd (ASX:IMU, OTC:IUGNF) welcomes the US Patent and Trademark Office’s (USPTO) granting of a crucial Notice of Allowance protecting the company’s.